---
figid: PMC9643318__fimmu-13-989972-g003
pmcid: PMC9643318
image_filename: fimmu-13-989972-g003.jpg
figure_link: /pmc/articles/PMC9643318/figure/f3/
number: FigureÂ 3
figure_title: ''
caption: Integrating transcriptomes and network-based drug repurposing. (A) Cellular
  gene expression signature. (B) Sensitive drugs with co-occurrence in GDSC1&2. (C)
  IC50 of drugs in primary focus and BMs. (D) Structure-based drug cluster analysis.
  (E) Network pharmacology of natural compounds. (F) Topology-based candidate natural
  compounds. (G) Pathway patterns of candidate natural compounds. (H) Rational structure
  compounds in the MedChemExpress database.
article_title: Integrating transcriptomics and network analysis-based multiplexed
  drug repurposing to screen drug candidates for M2 macrophage-associated castration-resistant
  prostate cancer bone metastases.
citation: Jinyuan Chang, et al. Front Immunol. 2022;13:989972.
year: '2022'

doi: 10.3389/fimmu.2022.989972
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.

keywords:
- drug repurposing
- castration-resistant prostate cancer
- bone metastases
- network pharmacology
- M2 macrophage

---
